Rosalind Franklin University


Rosalind Franklin University (RFU) is dedicated to advancing healthcare education and research through interprofessionalism and innovative practices. Named after Dr. Rosalind Franklin, the university fosters a collaborative environment for students and faculty to improve health outcomes and community wellness.

Rosalind Franklin University

Rosalind Franklin University


Patents

Combination serotonin specific reuptake inhibitor and serotonin 1A receptor partial agonist for reducing L-DOPA-induced dyskinesia

2025-04-29 • US-12285426-B2

View Details

Durability test system for repetitive loading of a prosthetic socket

2025-04-22 • US-12279979-B2

View Details

Antisense compounds targeting genes associated with cystic fibrosis

2024-07-23 • US-12042508-B2

View Details

CCN3 and CCN3 peptides and analogs thereof for therapeutic use

2024-07-02 • US-12024544-B2

View Details

Chromenopyridine-based compounds and methods of making and use thereof

2023-11-14 • US-11814392-B2

View Details

Methods of treating HIV-associated neurological disorders (HAND)

2023-10-17 • US-11786507-B2

View Details

What We Do

A pro bono clinic providing healthcare services to the uninsured, staffed by students from various health programs.

A mobile health service that provides primary care, vaccinations, podiatry, physical therapy, medication reconciliation, and behavioral health counseling to vulnerable populations.

A four-year program that prepares students for a career in medicine with a focus on patient-centered care and interprofessional collaboration.

Advanced nursing programs that prepare students for leadership roles in healthcare.

A comprehensive pharmacy program that emphasizes interprofessional education and hands-on experience in various healthcare settings.



Key People

James Carlson

Vice President for Interprofessional Education and Simulation

LinkedIn

Erin Howe

Cancer Biologist


News & Updates

December 17, 2024 — 4:30 pm - 6:30 pm

RFU has launched a campaign to help raise donations for free healthcare services in the local community, running until December 16, 2024.

U.P. Oncolytics, a company in Rosalind Franklin University’s Helix 51 biomedical incubator, has been awarded Orphan Drug designation by the FDA for its oncolytic virus-based therapy to treat malignant glioma.

RFU has launched a campaign to help raise donations for free healthcare services in the local community.

Dr. Erin Howe has been awarded a $100,000 grant from the Mary Kay Ash Foundation to study the immune recognition of brain cancer metastases.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.